Genomics and genome editing in the NHS inquiry
Inquiry by the Science and Technology Committee (Commons), 13 September 2017 to 9 September 2019. Its page on the Parliament website.
Reports and responses
- 3rd Report - Genomics and genome editing in the NHS (20 April 2018)
Evidence sessions
- 1 November 2017: Dr Magdalini Papadaki, Head of Product and Process Innovation, Association of the British Pharmaceutical Industry, and Professor Sir John Bell, Regius Professor of Medicine, University of Oxford; Dr Mark Kroese, Chair, Diagnostics Advisory Committee, National Institute for Health and Care Excellence, Professor Sue Hill, Chief Scientific Officer for England, NHS England, and Professor William Newman, Vice Chair, British Society for Genetic Medicine
- 28 November 2017: Dr Hilary Burton, Consultant in Public Health, PHG Foundation, Professor Sian Ellard, Clinical Programme Director, South West NHS Genomic Medicine Centre, and Fiona Murphy, Director, National Services Division, NHS National Services Scotland, and Member of the Scottish Genomes Partnership; Lord O’Shaughnessy, Parliamentary Under-Secretary of State, Department of Health, Professor Dame Sally Davies, Chief Medical Officer for England, and Professor Patrick Chinnery, Professor of Neurology, Cambridge University